This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
$0.06932
Share price
0.00%
Change (1 day)
-97.19%
Change (1 year)
Revenue for Amyris (AMRS)
Revenue in 2023 (TTM): C$0.35 Billion
According to Amyris's latest financial reports the company's current revenue (TTM 
) is C$0.37 Billion. In 2022 the company made a revenue of C$0.36 Billion a decrease over the revenue in the year 2021 that were of C$0.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amyris from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | C$0.35 B | -1.69% |
| 2022 | C$0.36 B | -15.94% |
| 2021 | C$0.43 B | 97.33% |
| 2020 | C$0.22 B | 10.8% |
| 2019 | C$0.19 B | 78.3% |
| 2018 | C$0.11 B | -38.03% |
| 2017 | C$0.18 B | 73.85% |
| 2016 | C$0.10 B | 118.96% |
| 2015 | C$47.37 M | -5.66% |
| 2014 | C$50.21 M | 14.73% |
| 2013 | C$43.77 M | -40.27% |
| 2012 | C$73.28 M | -50.99% |
| 2011 | C$0.14 B | 86.25% |
| 2010 | C$80.27 M | 18.09% |
| 2009 | C$67.98 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$15.92 B | 4,181.54% | 🇺🇸 USA |
 | C$7.45 B | 1,904.89% | 🇺🇸 USA |
 | C$0.33 B | -9.28% | 🇺🇸 USA |
 | C$3.40 B | 816.71% | 🇺🇸 USA |
 | C$23.45 M | -93.69% | 🇺🇸 USA |
 | C$17.17 B | 4,517.83% | 🇺🇸 USA |